4 years after Nestlé spent greater than $5bn to accumulate a clutch of nutritional vitamins and dietary supplements manufacturers, among the belongings look set for disposal.
The world’s largest meals firm stated right now (24 July) that it’s launching a “strategic evaluation of our mainstream and worth manufacturers” inside the nutritional vitamins, minerals and dietary supplements (VMS) enterprise.
Nestlé stated the belongings up for evaluation embody Nature’s Bounty, Osteo Bi-Flex and Puritan’s Delight, together with the private-label VMS enterprise within the US.
In 2021, the corporate forked out $5.75bn to buy these manufacturers, and the own-label operations within the US, from The Bountiful Firm. The deal struck with private-equity agency KKR additionally included Solgar.
Solgar is among the many “premium” VMS manufacturers that Nestlé stated right now will form its focus, together with Backyard of Life and Pure Encapsulations.
Nestlé made no point out on the way forward for the eight manufacturing services within the US that it acquired from Bountiful as a part of the KKR transaction.
Bountiful was initially based as Nature’s Bounty earlier than it was rebranded in 2017. The acquired belongings sit inside Nestlé’s Well being Science portfolio, which additionally homes the Atrium Improvements VMS belongings purchased in 2017 for $2.3bn.
“Our VMS enterprise will give attention to international premium manufacturers, reminiscent of Backyard of Life, Solgar and Pure Encapsulations the place our capabilities in science, innovation and brand-building give us a definite aggressive edge,” Nestlé defined in its outcomes announcement for the primary half of fiscal 2025.
Reported gross sales for Nestlé Well being Science dipped 0.4% to SFr3.2bn ($4bn) over the primary six months of the yr, though natural income was up 3.4%. Actual inside development (RIG), which strips out the impact from pricing on the natural numbers, was 3.3% with pricing of 0.1%.
“In VMS, development was impacted by the discontinuation of some private-label enterprise and weaker efficiency in our mainstream manufacturers, significantly Puritan’s Delight,” Nestlé stated.
It added that “gross sales momentum in premium manufacturers, significantly Pure Encapsulations and Solgar, was partially offset by declines in mainstream and worth manufacturers”, together with the lack of the own-label enterprise.
Barclays’ analysts led by Warren Ackerman wrote right now {that a} “strategic evaluation of mainstream VMS can be welcomed”, estimating gross sales of the belongings up for potential disposal at round SFr1bn.
Nestlé reiterated right now the “heightened dangers” it flagged on the first-quarter outcomes announcement in April round “persevering with macroeconomic and shopper uncertainties”.
These uncertainties are additionally evident in China, the place Nestlé stated right now it’s “taking steps to strengthen [its] development profile”.